4D Molecular Therapeutics (FDMT) Receivables - Net (2019 - 2021)
4D Molecular Therapeutics (FDMT) posted quarterly Receivables - Net of $47000.0 for Q4 2021, down 95.73% year-over-year from $1.1 million in Q4 2020, and down 94.12% quarter-over-quarter from $800000.0 in Q3 2021.
4D Molecular Therapeutics (FDMT) Receivables - Net (2019 - 2021) Analysis & Trends
4D Molecular Therapeutics (FDMT) has reported Receivables - Net for 3 consecutive years, with $47000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Receivables - Net fell 95.73% year-over-year to $47000.0; the TTM figure through Dec 2021 stood at $47000.0 (down 95.73% YoY), while the FY2021 annual figure was $47000.0, down 96.84% from the prior year.
- Receivables - Net slipped to $47000.0 in Q4 2021 per FDMT's latest filing, from $800000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $1.2 million in Q2 2021 and bottomed at $47000.0 in Q4 2021.
- Historically, Receivables - Net has averaged $749400.0 across 3 years, with a median of $800000.0 in 2021.
- Annual changes were most pronounced in 2020 — Receivables - Net surged 83.33% — and 2021, when it slumped 95.73%.
- 4D Molecular Therapeutics' Receivables - Net stood at $600000.0 in 2019, then surged by 83.33% to $1.1 million in 2020, then plunged by 95.73% to $47000.0 in 2021.
- Business Quant data shows FDMT's Receivables - Net at $47000.0 in Q4 2021, $800000.0 in Q3 2021, and $1.2 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 47,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Sep 30, 2021 | 800,000.00 |
| Sep 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.20 Mn |
| Dec 31, 2020 | 1.10 Mn |
| Dec 31, 2020 | 1.10 Mn |
| Dec 31, 2019 | 600,000.00 |
| Dec 31, 2019 | 600,000.00 |